The Food and Drug Administration has recently announced their plans to strengthen the side effects warnings on the packaging of the popular male pattern baldness medication Propecia after a number of men have come forward with reports that their side effects from the medication were... Read More

The growing number of Propecia lawsuit complaints, many of which allege Propecia erectile dysfunction, has prompted the Supreme Court of New Jersey to order consolidation into the Superior Court of Middlesex Country, where Judge Jessica R. Mayer will preside. Though the consolidated Propecia lawsuits have... Read More

Patients seeking information about male pattern baldness drug Propecia who consulted the medication's website, run by drug maker Merck, were surprised on February 8, 2012, when the company shut down the website with no warning or explanation. The website was later restored, but with no... Read More

Propecia lawsuit plaintiffs await a decision from a panel of federal judges, who will rule on whether Propecia litigation should be consolidated into multidistrict litigation (MDL). An MDL would help conserve resources and streamline pretrial processes, among other advantages. The panel's decision is expected soon,... Read More

Drug manufacturer Merck has shut down its Propecia website, causing many to speculate that new warnings will soon be added to the hair loss drug's side effects label. Currently, Sweden, the U.K. and Italy already issue strong warnings concerning the side effects resulting from Propecia... Read More

Propecia, or finasteride in its generic form, first received FDA approval in 1997 for the treatment of male pattern baldness and was soon marketed as the next generation in hair loss treatments. It was the first medication of its kind to be available in pill... Read More